急性红细胞白血病:从分子生物学到临床结果
Priyanka Fernandes1, Natalie Waldron1, Theodora Chatzilygeroudi2
1Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
International journal of molecular sciences
|June 19, 2024
概括
急性红细胞白血病 (AEL) 是一种激进的AML亚型,由特定的爆炸百分比和TP53突变来定义. 目前的治疗方法反应不佳,强调需要更好的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性红细胞白血病 (AEL) 是急性髓性白血病 (AML) 的一种罕见的,激进的亚型.
- 最近的分类通过特定的红色素前体百分比或TP53突变来定义AEL.
- AEL的特点是遗传复杂性,包括TP53突变和染色体缺失.
研究的目的:
- 要总结AEL的诊断标准.
- 审查目前对AEL生物学和病原学的理解.
- 描述AEL的治疗选择和患者的结果.
主要方法:
- 基于世卫组织和国际共识分类的诊断标准的审查.
- 对分子病原学的分析,包括遗传突变和转录调节剂.
- 临床结果和治疗反应的总结.
主要成果:
- AEL诊断涉及特定的红细胞/红细胞前体百分比或TP53突变.
- 病变发生涉及GATA1,CDX4和表观遗传调节剂等关键分子.
- 患者对标准疗法反应不佳,治疗选择有限.
结论:
- AEL具有独特的诊断和生物特征.
- 目前的治疗方法在很大程度上是无效的,导致结果不佳.
- 全基性骨髓移植提供了潜在的治疗方法,但需要深度缓解.
相关概念视频
01:14Erythropoiesis
4.2K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K
01:22Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324